Literature DB >> 7694467

Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy.

S M Sladek1, A C Regenstein, D Lykins, J M Roberts.   

Abstract

OBJECTIVE: Our purpose was to test a potential role for the endogenous smooth muscle relaxant nitric oxide in the control of gestational uterine activity by quantifying and characterizing its synthetic enzyme, nitric oxide synthase, in uterine tissue at the end of pregnancy. STUDY
DESIGN: We measured nitric oxide synthase activity through the conversion of tritiated L-arginine to tritiated L-citrulline in subcellular preparations of decidua and myometrium from pregnant rabbits at 27, 30, and 31 days' (term)gestation. Nitric oxide synthase was characterized by measuring its relative inhibition by arginine analogs and its calcium-calmodulin requirement. Nitric oxide synthase activities were compared by one-way analysis of variance with Fisher's post hoc test.
RESULTS: Nitric oxide synthase activity in decidua was high at 27 days' gestation (6.32 +/- 1.10 pmol/mg protein per minute, n = 6), less with the approach of labor (30 days = 3.16 +/- 1.25 pmol/mg per minute, n = 4), and lowest at 31 days (1.07 +/- 0.29 pmol/mg per minute, n = 4, p < 0.05). Decidual nitric oxide synthase was calcium insensitive, and arginine analogs reduced activity with potencies consistent with their effect on the induced form of nitric oxide synthase.
CONCLUSION: Decidual nitric oxide synthase activity, which has the characteristics of the inducible isoform of the enzyme, is significantly lower on the last day of gestation. This suggests a role for nitric oxide in the control of uterine contractility during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694467     DOI: 10.1016/0002-9378(93)90295-t

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

Review 1.  Racial differences in nitric oxide-dependent vasorelaxation.

Authors:  Eugenia Mata-Greenwood; Dong-Bao Chen
Journal:  Reprod Sci       Date:  2008-01       Impact factor: 3.060

2.  Cyclic GMP-independent effects of nitric oxide on guinea-pig uterine contractility.

Authors:  K A Kuenzli; M E Bradley; I L Buxton
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Effects of caffeine on placental total nitrite concentration: A 21-day, vehicle-controlled study in rats.

Authors:  Belgin Alasehirli; Mustafa Cekmen; Muradiye Nacak; Ayse Balat
Journal:  Curr Ther Res Clin Exp       Date:  2005-03

4.  Expression and localization of inducible and endothelial nitric oxide synthase in the rat ovary. Effects of gonadotropin stimulation in vivo.

Authors:  B J Van Voorhis; K Moore; P J Strijbos; S Nelson; S A Baylis; D Grzybicki; C P Weiner
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy.

Authors:  C H Acevedo; A Ahmed
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  A decline in myometrial nitric oxide synthase expression is associated with labor and delivery.

Authors:  R K Bansal; P C Goldsmith; Y He; C J Zaloudek; J L Ecker; R K Riemer
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 7.  Nitric oxide donors for treating preterm labour.

Authors:  Kirsten Duckitt; Steve Thornton; Oliver P O'Donovan; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2014-05-08

8.  Nitric oxide and antioxidant enzymes in venous and cord blood of late preterm and term omani mothers.

Authors:  Clifford Abiaka; Lovina Machado
Journal:  Sultan Qaboos Univ Med J       Date:  2012-07-15

9.  Characterization of the myometrial transcriptome in women with an arrest of dilatation during labor.

Authors:  Piya Chaemsaithong; Ichchha Madan; Roberto Romero; Nandor Gabor Than; Adi L Tarca; Sorin Draghici; Gaurav Bhatti; Lami Yeo; Moshe Mazor; Chong Jai Kim; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Perinat Med       Date:  2013-11       Impact factor: 1.901

10.  Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.

Authors:  Tracy A Manuck; W Scott Watkins; Barry Moore; M Sean Esplin; Michael W Varner; G Marc Jackson; Mark Yandell; Lynn Jorde
Journal:  Am J Obstet Gynecol       Date:  2014-03-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.